BCLC 2025 Guidelines introduce a new model to personalize liver cancer treatment
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clín...
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clín...
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer...
Funded by the Spanish Association Against Cancer (AECC) and coordinated by IDIBAPS and the Salamanca Cancer Research Centre, ASPIRE-AECC aims to im...
A team of researchers from the Clínic-IDIBAPS have analysed the capacity of an artificial intelligence model to classify liver lesions after a magn...
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet...
Researchers from the Hospital Clínic-IDIBAPS have participated in the preparation of the new guidelines on intrahepatic cholangiocarcinoma, the sec...
In an important breakthrough in precision medicine and for the approval of cost-effective treatments, the expression of eleven genes is found to ma...
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which th...